| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $2.30 | $2.92 | $2.82 | $3.27 | $3.48 | $0.89 | $0.51 | $0.50 |
| EPS (Diluted) | $2.29 | $2.91 | $2.82 | $3.26 | $3.47 | $0.89 | $0.51 | $0.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.5B | $8.5B | $8.3B | $7.6B | $7.3B | $7.0B | $6.7B | $6.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.4B | $0.6B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $7.7B | $7.7B | $7.5B | $6.8B | $6.3B | $6.1B | $5.9B | $5.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.8B | $0.8B | $0.8B | $0.7B | $0.9B | $0.9B | $0.8B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.0B | $-0.4B | $-0.3B | $-0.6B | $-0.2B | $-0.2B | $-0.6B | $0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.1B | $0.1B | $0.6B | $0.4B | $0.1B | $0.1B | $0.5B | $-0.5B |